Clinical Knowledge Service of the NHS Institute for Innovation and Improvement Pandemic influenza definition Click to link Accessed June 2009
NHS Direct Patient information leaflets: Pneumococcal infections Click to link Accessed June 2009
Department of Health Immunisation against infectious disease - "The Green Book" Chapter 25 Click to link Accessed June 2009
NHS Direct Patient information leaflets: Pneumonia Click to link Accessed June 2009
NHS Direct Patient information leaflets: Meningitis Click to link Accessed June 2009
NHS Direct Patient Leaflet: Otitis Externa Click to link Accessed June 2009
Department of Health. Immunisation against infectious disease - "The Green Book". Influenza Chapter 19 Click to link Accessed June 2009
Department of Health. Types of Meningitis. Click to link Accessed June 2009
NHS Direct. Colds and Flu Advice. Click to link Accessed June 2009
Mangtani P, Cumberland P, Hodgson CR, Roberts JA, Cutts FT, Hall AJ. A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. Journal of Infectious Diseases. 2004 Jul 1; 190(1): 1-10
Johnson NP, Mueller J. Updating the accounts: global mortality of the 1918-1920 "Spanish" influenza pandemic. Bulletin of the History of Medicine. 2002 Spring; 76(1): 105-15
World Health Organisation. Cumulative Number of Confirmed Human Cases of Avian Influenza A/(H5N1) Reported to WHO. 2nd June 2009. Click to link Accessed June 2009
Department of Health Green Book updateChapter 19 influenza Department of Health Statement Influenza Swine Flu Click to link Accessed June 2009
Clinical Knowledge Service of the NHS Institute for Innovation and Improvement Prevalence Click to link Accessed June 2009
Clinical Knowledge Service of the NHS Institute for Innovation and Improvement Infectivity UK Government Department of Health NHS Guide: Explaining Pandemic Flu A report by the Chief Medical Officer October 2005 Click to link Accessed June 2009
Health Protection Agency: Frequently asked Questions Influenza Click to link Accessed June 2009
Clinical Knowledge Service of the NHS Institute for Innovation and Improvement Risk Click to link
Clinical Knowledge Service of the NHS Institute for Innovation and Improvement Avian Flu incubation Click to link
Department of Health. Flu FAQ. Click to link Accessed March 2009
Clinical Knowledge Service of the NHS Institute for Innovation and Improvement Incubation Click to link
Voelker, R. (1999) Fighting the flu. Journal of the American Medical Association 281(2), 123.
Clinical Knowledge Service of the NHS Institute for Innovation and Improvement Prognosis Click to link
National Health Service.NHS Choices Influenza symptoms Click to link Accessed June 2009
Department of Health. Chief Medical Office Letter: The influenza immunisation programme 2008/09. Click to link Accessed March 2009
Department of Health. PL CMO (2008)3, PL CNO (2008)2, PL CPHO (2008)1: The influenza immunisation programme 2008/09 Click to link Accessed June 2009
National Health Service. Active immunity. Click to link Accessed June 2009
National Health Service. About the vaccine. Click to link Accessed June 2009
National Health Service. What is a vaccine? Click to link Accessed June 2009
National Health Service. Can the vaccine cause flu? Click to link Accessed June 2009
Health Protection Agency FAQ webpage Click to link Accessed June 2009
National Health Service. Are there any side effects from the vaccine? Click to link Accessed June 2009
National Health Service. Is there anyone who should not be given a flu vaccine? Click to link Accessed June 2009
Disease information, Meningitis Research Foundation website. Click to link Accessed May 2009
Baraff LJ, Lee SI, Schriger DL. Outcomes of bacterial meningitis in children: a meta-analysis. Pediatr Infect Dis J 1993; 12: 389-394
Meningitis Research Foundation Click to link Accessed May 2009
Laurichesse H, Grimaud O, Waight P et al. Pneumococcal bacteraemia and meningitis in England and Wales, 1993 to 1995. Commun Dis Public Health 1998; 1: 22-27
Van de Beek D, de Gans J, Spanjaard L et al. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 2004;351:1849-1859
Schuchat A, Robinson K, Wenger JD, et al. Bacterial meningitis in the United States in 1995. N Engl J Med 1997;337:970-976
Davison KL, Ramsay ME. The epidemiology of acute meningitis in children in England and Wales. Arch Dis Child 2003; 88: 662-664
Meningitis Research Foundation Click to link Accessed May 2009
Tully J, Viner RM, Coen PG et al. Risk and protective factors for meningococcal disease in adolescents: matched cohort study. BMJ 2006; 332: 445-450
Health Protection Agency, meningococcal epidemiology Click to link Accessed May 2009
Health Protection Agency, pneumococcal disease epidemiology Click to link Accessed May 2009
Health Protection Agency, mumps general information Click to link Accessed May 2009
The Meningitis Trust, Viral Meningitis, The Facts Click to link Accessed May 2009
The Meningitis Research Foundation Click to link Accessed May 2009
Baraff L et al. Outcomes of bacterial meningitis in children: a meta-analysis. Paed Infect Dis J 1993; 12:389-394
Van Heerbeek N, Straetemans M, Wiertsema SP et al. Effect of combined pneumococcal conjugate and polysaccharide vaccination on recurrent otitis media with effusion. Pediatrics 2006; 117(3): 603-8
Froom J, Culpepper L, Jacobs M et al. Antimicrobials for acute otitis media? A review from the International Primary Care Network. BMJ 1997; 315: 98-102
Djuretic T, Ryan MJ, Miller E et al. Hospital admissions in children due to pneumococcal pneumonia in England. J Infect 1998; 37: 54-58
Rovers MM et al. Otitis Media. Lancet 2004; 363: 465-473
Treating otitis media, NHS Choices website. Click to link Accessed May 2009
Dewey KG, Heinig MJ, Nommsen-Rivers LA (1995). "Differences in morbidity between breast-fed and formula-fed infants". J. Pediatr. 126 (5 Pt 1): 696 702
Niemela M, Uhari M, Mottonen M. A pacifier increases the risk of recurrent acute otitis media in children in day care centers. Paediatrics. 1995; 96 (5 Pt 1): 8 84-8
Kraemer MJ, Richardson MA, Weiss NS et al. Risk factors for persistent middle-ear effusions. Otitis media, catarrh, cigarette smoke exposure, and atopy. JAMA 1983; 249(8): 1022-5.
Almirall J, Bol’bar I, Balanz— X, Gonzalez CA (February 1999). "Risk factors for community-acquired pneumonia in adults: a population-based case-control study". Eur. Respir. J. 13 (2): 349 55. PMID 10065680. Click to link
Jackson M et al. Influenza vaccination and risk of community-acquired pneumonia in immunocompetent elderly people: a population-based, nested case-control study. Lancet, 2008; 9396:373-384
The British Thoracic Society Guidelines for the Management of Community Acquired Pneumonia in Adults , 2001/2004/draft update 2009
WHO Weekly epidemiological record, No. 42, 2008, 83, 373 384
Hoare Z, Lim WS. Pneumonia: update on diagnosis and management. BMJ 2006 332: 1077-79
Health Protection Agency (HPA). HPA Annual Report 2006
Simonsen L. The global impact of influenza on morbidity and mortality. Vaccine 1999; (Suppl 1): S3-10
Lung Health in Europe; a better understanding of lung disease and respiratory care in Europe facts & figures, published by the European Respiratory Society, 2004
De Roux, Ewig S, Garcia E. et al. Mixed community-acquired pneumonia in hospitalised patients. Eur Respir J 2006; 27: 795-800
Prevention of Pneumococcal Disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). April 4, 1997 / Vol. 46 / No. RR-8
British Lung Foundation Click to link Accessed
National Foundation for Infectious Diseases Click to link
Immunisation against infectious diseases The Green Book
National Health Service. Immunisation schedule. Click to link Accessed March 2009
Health Protection Agency. Vaccination schedule. Click to link Accessed March 2009
Clinical Knowledge Summaries. Immunisations, adult. Click to link Accessed March 2009
Health Protection Agency. Pneumococcal Vaccination Recommendations. Click to link Accessed March 2009
Department of Health. CMO Letter 1999 Click to link Accessed June 2009
Department of Health. Joint Committee on Vaccination and Immunisation: Minutes of the Pneumococcal subgroup, Friday 7 September 2007. Click to link Accessed June 2009
World Health Organisation. Recommended composition of influenza virus vaccines for use in the 2009-2010 northern hemisphere influenza season. Click to link Accessed June 2009
UK NHS Institute for Innovation and Improvement; Clinical Knowledge Summaries;: Influenza Click to link
UK Department of Health Statement: Influenza Swine Flu Click to link Accessed June 2009
Blank PR, Freiburghaus AU, Schwenkglenks M, Szucs TD. Trends in influenza vaccination coverage rates in the United Kingdom over six seasons from 2001-2 to 2006-7. European communicable disease bulletin. 2008 Oct 23; 13(43). pii: 19014
Department of Health. Catch it, Bin it, Kill it - Respiratory and hand hygiene campaign.Click to link Accessed June 2009
UK NHS Institute for Innovation and Improvement; Clinical Knowledge Summaries;: Pneumococcal Disease Click to link Accessed July 2009
Johnson AP et al. Morbidity and mortality of pneumococcal meningitis and serotypes of causative strains prior to introduction of the 7-valent conjugant pneumococcal vaccine in England. .J Infect, 2007; Nov; 55(5):394-9. Epub 2007 Aug 27
Balmer P, Falconer M, McDonald P, Andrews N, Fuller E, et al.ÔImmune Response to Meningococcal Serogroup C Conjugate Vaccine in Asplenic Individuals.Õ,Infection and Immunity. 72:332-337
Meningitec Summary of Product Characteristics, December 2008
Immunisation against infectious disease - "The Green BookÕ 2006 Chapter 22: Meningococcal Disease
Trotter CL, Andrews NJ, Kaczmarski EB, Miller E, et al. 2004. Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Lancet 2004; 364: 365 67
Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen JR, Elvin L, Ensor KM, Hackell J, Siber G, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 2000; 19(3):187 95.
CDC. Direct and Indirect Effects of Routine Vaccination of Children with 7 Valent Pneumococcal Conjugate Vaccine on Incidence of Invasive Pneumococcal Disease United States, 1998 2003.
Chief Medical Officer Letter (July 2006). Click to link
Choo S, Seymour L, Morris R, Quataert S, Lockhart S, Cartwright K, Finn A. Immunogenicity and reactogenicity of a pneumococcal conjugate vaccine administered combined with a Haemophilus influenzae type b conjugate vaccine in United Kingdom infants. Pediatr Infect Dis J 2000; 19(9): 854 862.
Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, Herva E, Takala A, Kayhty H, Karma P, Kohberger R, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 2001; 344(6): 403-9.
Goldblatt D, ,Southern J, Ashton L, Richmond P, Burbidge P, Tasevska J,Crowley-Luke A, Andrews N, Morris R, Borrow R,Cartwright K, Miller E. Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlers.PIDJ 2006; 25:312-319.
Grijalva et al. Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis. The Lancet. 2007; 369:1179-1186.
HPA. CDR Weekly: Invasive pneumococcal infection England and Wales 2001; 11;21
HPA. Cumulative Weekly Reports IPD. Click to link Last Accessed Oct 2007
Health Protection Scotland. HPS Weekly Report. Feb 2009. Volume 43
JCVI Pneumococcal Subgroup Minutes, January 2009
Käyhty H, Ahman H, Eriksson K, Sörberg M, Nilsson L. Immunogenicity and tolerability of a heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 12 months of age. Pediatr Infect Dis J 2005; 24: 108-114.
MMWR Weekly 2005; 54:893 897. COVER data, Quarterly Vaccination Coverage Statistics. Health Protection Report. Volume 1 Number 38. September 2007.
Prevenar Summary of Product Characteristics. January 2009
The Green Book replacement chapters. Click to link Accessed October 2007
Rennels MB, Edwards KM, Keyserling HL, Reisinger KS, Hogerman DA, Madore DV, Chang I, Paradiso PR, Malinoski FJ, Kimura A. Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants. Pediatrics. 1998;101: 604-611.
Shinefield H, Black S, Ray P, Fireman B, Schwalbe J, Lewis E. Efficacy, immunogenicity and safety of heptavalent pneumococcal conjugate vaccine in low birth weight and preterm infants. Pediatr Infect Dis J 2002; 21: 182-186.
Whitney et al, Decline in invasive pneumococcal disease after the introduction of protein polysaccharide conjugate vaccine. NEJM 2003; 348: 1737-46.
Electronic Medicines Compendium. Enzira Summary of Product Characteristics. Click to link, Accessed June 2009
Electronic Medicines Compendium. Enzira Patient Information Leaflet Click to link, Accessed June 2009
Medicines and Healthcare products Regulatory Agency. Reporting suspected adverse drug reactions and suspected defects in medicinal products. Click to link, Accessed April 2009
World Health Organization Global Immunization Vision and Strategy 2006-7 Page 3. Ordering code: WHO/IVB/05.05; Printed: October 2005; available on the internet at: Click to link
UK NHS Health Protection Agency: Goals and Programmes: Key Health Protection Programmes Click to link, last accessed 18/08/2009
RMS 13568 - Wyeth Flu Questionnaire 2008
Fangjun Zhou, Abigail Shefer, Yuan Kong and J. Pekka Nuorti. (2008) Trends in Acute Otitis Media-Related Health Care Utilization by Privately Insured Young Children in the United States, 1997_2004. 121;253-260 Pediatrics
Department of Health. Types of Meningitis. Click to link, Last accessed June 2009
World Health Organisation. Recommended composition of influenza virus vaccines for use in the 2009-2010 northern hemisphere influenza season Click to link, Last accessed June 2009
Department of Health. Immunisation against infectious disease - 'The Green Book'. Influenza Chapter 19 Click to link, Last accessed June 2009
NHS Immunisation Information, Click to link